News Cancer worries halt shipments of generic Zantac September 19, 2019Nathan Bomey, USA TODAYComments Off on Cancer worries halt shipments of generic Zantac A division of Novartis is reportedly halting distribution of generic Zantac pills amid concerns about an ingredient possibly linked to cancer.